Inventor · disambiguated record
Daniel P. Zimmer
Also filed as: ZIMMER DANIEL · ZIMMER DANIEL P
11 granted patents·15 pending applications·68 citations·filing 2004–2023
88Inventor score
Files withCURRIE MARK G9IRONWOOD PHARMACEUTICALS INC9MICROBIA INC5SCHUELE VOLKER1WORCESTER POLYTECH INST1
Top patents by PatentIndex Score
26 records- 0191US9139564B22-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2012·Granted Sep 22, 2015·15 cites·6 claims
- 0287US8507447B2Treatments for gastrointestinal disordersCURRIE MARK G·Filed 2010·Granted Aug 13, 2013·12 cites·30 claims
- 0382US9303066B2Treatments for gastrointestinal disordersCURRIE MARK G·Filed 2012·Granted Apr 5, 2016·3 cites·21 claims
- 0481US8946158B2Treatments of gastrointestinal disordersIRONWOOD PHARMACEUTICALS INC·Filed 2013·Granted Feb 3, 2015·5 cites·35 claims
- 0581US8735360B2Treatments for gastrointestinal disordersCURRIE MARK G·Filed 2010·Granted May 27, 2014·5 cites·36 claims
- 0681US7320972B24-Biarylyl-1-phenylazetidin-2-onesMICROBIA INC·Filed 2004·Granted Jan 22, 2008·24 cites·71 claims
- 0776US8779090B2Methods and compositions for the treatment of heart failure and other disordersZIMMER DANIEL·Filed 2008·Granted Jul 15, 2014·3 cites·1 claims
- 0874US9617305B2Treatments for gastrointestinal disordersCURRIE MARK G·Filed 2012·Granted Apr 11, 2017·1 cites·43 claims
- 0958US2010010046A1Pharmaceutical formulation for parenteral administrationIRONWOOD PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1057US2014256634A1Treatments for Gastrointestinal DisordersIRONWOOD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1157US2010144864A1Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disordersIRONWOOD PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1254US2024192198A1Biomimetic liposomes and methods of making and using the sameWORCESTER POLYTECH INST·Filed 2023·Application pending·0 cites
- 1351US2008167255A14-biarylyl-1-phenylazetidin-2-onesMICROBIA INC·Filed 2007·Application pending·0 cites
- 1450US2013123354A1Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disordersIRONWOOD PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1549US2012040025A9Compositions and Methods for Treating Disorders Associated with Salt or Fluid RetentionCURRIE MARK G·Filed 2008·Application pending·0 cites
- 1648US2012283411A9Methods and compositions for the treatment of gastrointestinal disordersCURRIE MARK G·Filed 2007·Application pending·0 cites
- 1746US2012028897A1Methods and compositions for the treatment of fluid retention disordersCURRIE MARK G·Filed 2009·Application pending·0 cites
- 1845US2015119328A1Treatments for Gastrointestinal DisordersIRONWOOD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1943US2009186834A1Diphenylheterocycle cholesterol absorption inhibitorsMICROBIA INC·Filed 2006·Application pending·0 cites
- 2042US9527887B2Treatments for gastrointestinal disordersCURRIE MARK G·Filed 2012·Granted Dec 27, 2016·0 cites·34 claims
- 2142US2015342954A12-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sgc stimulatorsIRONWOOD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2240US9650417B2Treatments for gastrointestinal disordersCURRIE MARK G·Filed 2012·Granted May 16, 2017·0 cites·31 claims
- 2340US2016213739A1Treatments for disorders using guanylate cyclase c agonistsIRONWOOD PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2439US2009131395A1Biphenylazetidinone cholesterol absorption inhibitorsMICROBIA INC·Filed 2006·Application pending·0 cites
- 2538US2009005321A1Phenylazetidinone DerivativesMICROBIA INC·Filed 2006·Application pending·0 cites
- 2636US10253973B2System for combined flue gas heat recovery and dust precipitation improvement as retrofit solution for existing coal-fired power stationsSCHUELE VOLKER·Filed 2011·Granted Apr 9, 2019·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Daniel P. Zimmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →